Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access October 7, 2010

Reconstructive options in severe cases of Hidradenitis suppurativa

Birol Civelek, Kadir Aksoy, Esra Bilgen, Ibrahim İnal, Unal. Sahin and Selim Çelebioğlu
From the journal Open Medicine


Hidradenitis suppurativa is a chronic, debilitating inflammatory disease of apocrine glands characterized with abscesses and nodular lesions. The treatment of Hidradenitis suppurativa consists of topical antibacterial or antiseptic solutions, systemic antibiotics, steroids, hormonal therapy, anti-tumor necrosis factor, and various surgical procedures. In this report, we present a series of 14 cases with severe Hidradenitis suppurativa. Surgical options are reviewed to show the best outcomes in the long term. A total of 14 patients (9 female, 5 male) were treated for advanced cases of Hidradenitis suppurativa. They underwent excision of the affected regions followed by reconstruction. The reconstruction methods consisted of split-thickness skin grafting and various cutaneous and myocutaneous flaps. There was no flap necrosis or dehiscence. One patient developed contracture in the axilla, for which he underwent release surgery. There were recurrences in 4 cases. There was no limitation of the arm movements in cases with flap reconstruction. In the long-term, they were satisfied with the results. In conclusion, incision and drainage should be avoided because it is of limited value. Surgical removal of the involved tissue should be the first treatment of choice. Depending on the defect following excision, local flaps should be preferred over the grafts for recurrence prevention.

[1] Pedraz J, Dauden E, Perez-Gala S et al. Hidradenitis suppurativa. Response to treatment with infliximab. Actas Dermosifiliogr 2007;98:324–331 Search in Google Scholar

[2] Pedras J, Dauden E. Practical management of Hidradenitis suppurativa. Actas Dermosifiliogr 2008;99:101–110 in Google Scholar

[3] Tanaka A, Hatoko M, Tada H et al. Experience with surgical treatment of Hidradenitis suppurativa. Ann Plast Surg 2001;47(6):636–642 in Google Scholar

[4] Moschella SL. Int J Dermatol 2007;46:1287–1291 in Google Scholar

[5] Mekkes JR, Bos JD. Long-term efficacy of a single course of infliximab in Hidradenitis suppurativa. Br J Dermatol 2008;158:370–374 in Google Scholar

[6] Lam J, Krakowski AC, Friedlander SF. Hidradenitis suppurativa (acne inversa):management of a recalcitrant disease. Ped Dermatol 2007;24(5):465–473 in Google Scholar

[7] Jansen T, Altmeyer P, Plewig G. Acne inversa (alias Hidradenitis suppurativa). J Eur Acad Dermatol Venereol 2001;158:370–374 10.1046/j.1468-3083.2001.00303.xSearch in Google Scholar

[8] Slade DEM Powell BW, Mortimer PS. Hidradenitis suppurativa:pathogenesis and management. Br J Plast Surg 2003;56:451–461 in Google Scholar

[9] Konig A, Lehmann C, Rompel R et al. Cigarette smoking as a triggering factor of Hidradenitis suppurativa. Dermatology 1999;198:261–264 in Google Scholar PubMed

[10] Goischke HK, Ochsendorf FR. Acne inversa in Chrohn’s disease. Z Gastroenterol 2001;39:965–969 in Google Scholar PubMed

[11] Ostlere LS, Langtry JA, Mortimer PS et al. Hidradenitis suppurativa in Chrohn’s disease. Br J Dermatol 1991;125:384–386 in Google Scholar PubMed

[12] Buimer MG, Ankersmit MFP, Wobbes T et al. Surgical treatment of Hidradenitis suppurativa with gentamycin sulfate: a prospective randomized study. Dermatol Surg 2008;34(2):224–227 in Google Scholar PubMed

[13] Ebling FJ. Apocrine glands in health and disorder. Int J Dermatol 1989;28:419–423 in Google Scholar PubMed

[14] Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of Hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 1995;133:254–258 in Google Scholar PubMed

[15] Aksakal AB, Adisen E. Hidradenitis suppurativa importance of early treatment;efficient treatment with electrosurgery. Dermatol Surg 2008; 34(2):228–231 in Google Scholar PubMed

[16] Giamarellos-Bourboulis EJ, Pekekanou E, Antonopoulou H et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of Hidradenitis suppurativa. Br J Dermatol 2008: 158;567–572 in Google Scholar PubMed

[17] Fardet L, Dupuy A, Kerob D et al. Infliximab for severe Hidradenitis suppurativa transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007;56(4):624–628 in Google Scholar PubMed

[18] Altmann S, Fansa H, Schneider W. Axillary Hidradenitis suppurativa:a further option for surgical treatment. J Cutan Med Surg 2004;8(1):6–10 in Google Scholar PubMed

[19] Banerje AK. Surgical treatment of Hidradenitis suppurativa. Br J Surg 1992; 79:863–866 in Google Scholar PubMed

[20] Amarante J, Reis J, Comba AS et al. A new approach in axillary hidradenitis treatment:the scapular island flap. Aesth Plast Surg 1996;20:443–446 in Google Scholar PubMed

[21] Harrison B, Mudge M, Hughes LE. Recurrence after surgical treatment of Hidradenitis suppurativa. Br Med J 1987;294:487–489 in Google Scholar PubMed PubMed Central

[22] Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with Hidradenitis suppurativa. Dermatol Surg 2000;26(7):638–643 in Google Scholar

[23] Soldin MG, Tulley P, Kaplan H et al. Chronic axillary hidradenitis —the efficacy of wide excision and flap coverage. Br J Plast Surg 2000;53;434–436 in Google Scholar

[24] Silverberg B, Smoot CE, Landa SJF et al. Hidradenitis suppurativa: patient satisfaction with wound healing by secondary intention. Plast Reconstr Surg 1987;79:555–559 in Google Scholar

[25] Amarente J, Reis, Comba AS et al. A new approach in axillary hidradenitis treatment: the scapular island flap. Aesth Plast Surg 1996;20;443–446 in Google Scholar

[26] Schwabegger AH, Herczeg E, Piza H. The lateral thoracic fasciocutaneous island flap for treatment of recurrent hidradenitis axillaris suppurativa and other axillary skin defects. Br J Plast Surg 2000;53(8):676–678 in Google Scholar

[27] Elliot D, Kangesu L, Bainbridge C et al. Reconstruction of the axilla with a posterior arm fasciocutaneous flap. Br J Plast Surg 1992;45:101–104 in Google Scholar

[28] Geh JL, Niranjan NS. Perforator based fasciocutaneous island flaps for the reconstruction of axillary defects following excision of Hidradenitis suppurativa. Br J Plast Surg 2002;55(2):124–128 in Google Scholar PubMed

[29] Rehman N, Kanan RY, Hassan S et al. Thoracodorsal artery perforator (TAP) type I V-Y advancement flap in axillary Hidradenitis suppurativa. Br J Plast Surg 2005;58:441–444 in Google Scholar PubMed

[30] Lipshutz H. Closure of axillary hidradenitis defects with local triangular flaps. Plast Reconstr Surg 1974;53:677–679 in Google Scholar PubMed

[31] O’Brien J, Wysocki J, Anastasi G. Limberg flap coverage for axillary defects resulting from excision of Hidradenitis supurtiva. Plast Reconstr Surg 1976;58:354–357 in Google Scholar PubMed

[32] Yii NW, Niranjan NS. Lotus petal flaps in vulvo-vaginal reconstruction. Br J Plast Surg. 1996;49(8):547–554 in Google Scholar

[33] Gravvanis AI, Tsoutsos DA, Karakitsos D et al. Application of the pedicled anterolateral thigh flap to defects from the pelvis to the knee. Microsurgery 2006;26:432–438 in Google Scholar

[34] Wisemann MC. Hidradenitis suppurativa: a review. Dermatol Ther 2004;17:50–54 in Google Scholar

[35] Ritz JP, Runkel N, Haier J et al. Extent of surgery and recurrence rate of Hidradenitis suppurativa. Int J Colorectal Dis 1998;13:164–168 in Google Scholar

[36] Weyand G. Surgical Management of acne inversa. Hautarzt 2005;56:1033–1039 in Google Scholar

[37] Mandal A, Watson J. Experience with different treatment modules in Hidradenitis suppurativa: a study of 106 cases. Surgeon 2005;3:23–26 in Google Scholar

[38] Giovannini U, Giannasi S. Fasciocutaneous flap to treat Verneuil disease (Hidradenitis suppurativa) in the axillary region. Plast Reconstr Surg 2003;50(1):108–109 10.1097/00000637-200301000-00030Search in Google Scholar PubMed

Published Online: 2010-10-7
Published in Print: 2010-12-1

© 2009 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow